The potential role of α‐synuclein as disease modifying therapies in Parkinson’s disease

Activity: Talk or presentation › Oral presentation

Description

Part I: The physiological role of α‐synuclein
Part II: α‐Synuclein‐mediated pathogenesis of PD
Period3 Apr 2020
Event titleAdvances in Alzheimer's and Parkinson's therapies : An AAT-AD/PD Focus meeting
Event typeConference
Degree of RecognitionInternational